These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11798979)

  • 21. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marker of T-cell activation is elevated in refractory Kawasaki disease.
    Suzuki H; Suenaga T; Takeuchi T; Shibuta S; Yoshikawa N
    Pediatr Int; 2010 Oct; 52(5):785-9. PubMed ID: 20487370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Kawasaki disease be managed?
    Coustasse A; Larry J; Lee D
    Perm J; 2012; 16(2):70-2. PubMed ID: 22745623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP; Yan WL; Huang M; Huang MR; Chen S; Huang GY; Liu F
    J Epidemiol; 2020 Oct; 30(10):429-435. PubMed ID: 31548437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
    Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U
    J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
    Hamada H; Suzuki H; Onouchi Y; Ebata R; Terai M; Fuse S; Okajima Y; Kurotobi S; Hirai K; Soga T; Ishiguchi Y; Okuma Y; Takada N; Yanai M; Sato J; Nakayashiro M; Ayusawa M; Yamamoto E; Nomura Y; Hashimura Y; Ouchi K; Masuda H; Takatsuki S; Hirono K; Ariga T; Higaki T; Otsuki A; Terauchi M; Aoyagi R; Sato T; Fujii Y; Fujiwara T; Hanaoka H; Hata A;
    Lancet; 2019 Mar; 393(10176):1128-1137. PubMed ID: 30853151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS; Lee J; Lee KC
    Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL; Zhao SL
    Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent Kawasaki disease with uveitis.
    Callaway LK; Bennett CJ
    Intern Med J; 2002 Aug; 32(8):421-2. PubMed ID: 12162401
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
    Dhanrajani A; Chan M; Pau S; Ellsworth J; Petty R; Guzman J
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1536-1540. PubMed ID: 29287309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N; Matsui H; Fushimi K; Yasunaga H
    Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000-2002)].
    Chemli J; Kchaou H; Amri F; Belkadhi A; Essoussi AS; Gueddiche N; Harbi A
    Tunis Med; 2005 Aug; 83(8):477-83. PubMed ID: 16238276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.